MolecuLightDX Measurement Feature Clinical Validation

RecruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
WoundsWound of Skin
Interventions
DEVICE

MolecuLight DX Imaging Device

The MolecuLight DX Imaging Device is a fluorescence imaging device intended to acquire images from wounds. This will not alter the participant's standard of care treatment.

Trial Locations (2)

L8R 2R3

RECRUITING

The Mayer Institute, Hamilton

M1E 4B9

NOT_YET_RECRUITING

SHN Research Institute, Scarborough Village

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MolecuLight Inc.

INDUSTRY

NCT06682923 - MolecuLightDX Measurement Feature Clinical Validation | Biotech Hunter | Biotech Hunter